Seleno-organic compounds as immunostimulants: An approach to the structure-activity relationship

Archivum Immunologiae et Therapiae Experimentalis

Volumn 44, Issue 1, 1996, Pages 67-75

  Inglot, Anna D ^a   MŁochowski, Jacek ^b   Zielińska Jenczylik, Janina ^a   Piasecki, Egbert ^a   Ledwoń, Tomasz K ^a   Kloc, Krystian ^b  

^a Polish Academy of Sciences   (Poland)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

cytokines; ebselen; human peripheral blood leukocytes; immunostimulants; interferon and tumor necrosis factor inducers; seleno organic compounds

Indexed keywords

EBSELEN; IMMUNOSTIMULATING AGENT; INTERFERON; ORGANOSELENIUM DERIVATIVE; TUMOR NECROSIS FACTOR;

ARTICLE; CHEMICAL STRUCTURE; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKOCYTE; STRUCTURE ACTIVITY RELATION;

ADJUVANTS, IMMUNOLOGIC; ANTIVIRAL AGENTS; AZOLES; BIOLOGICAL ASSAY; INTERFERONS; LEUKOCYTES; ORGANOSELENIUM COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029885349     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BECK M., A., KOLBECK P. C., ROHR L. H., SHI Q., MORRIS V. C. and LEV ANDER O. A. (1994): Benign human enterovirus becomes virulent in selenium-deficient mice. J. Med. Virol., 43, 166-170.
2. BEHNE D., WEISS-NOWAK C., KALCKLÖSCH M., WESTPHAL C., GESSNER H. and KYRIAKOPOULOS A. (1995). Studies on the distribution and characteristics of new mammalian selenium-containing proteins. Analyst, 120, 823-825.
3. BLASZCZYK B., INGLOT A. D., KOWALCZYK-BRONISZ S. H., SZYMANIEC S. and MŁOCHOWSKI J (1995): Immunotropic activities of benzisoselenazolones and organic diselenides in mice. Arch. Immunol. Ther. Exp., 43, 305-311.
4. BŁASZCZYK B., INGLOT A. D., TOIVANEN P., MŁOCHOWSKI J. and SZYMANIEC S. (1995): Effect of benzisoselenazolones and organic diselenides on graft versus host reaction and immunoglobulins levels in chickens. Arch. Immunol. Ther. Exp., 43, 299-303.
5. CEMBRZYŃSKA-NOWAK M. and INGLOT A D. (1992): Human lymphoid target cells for the cytokine-inducing seleno-organic compounds. Arch. Immunol. Ther. Exp., 40, 235-240.
6. CZYRSKI J. A and INGLOT A. D. (1991): Mitogenic activity of seleno-organic compounds in human peripheral blood leukocytes. Experientia, 47, 95-97.
7. DWORKIN B. M. (1994): Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem. Biol. Interact., 91, 181-186.
8. GIELDANOWSKI J., KOWALCZYK-BRONISZ S. H. and BLASZCZYK B. (1990): Immunopharmacological indices of piroxicam. Arch. Immunol. Ther. Exp., 38, 239-247.
9. HADDEN J. W. (1993): Immunostimulants. Immunol. Today, 14, 275-280.
10. INGLOT A. D., LESZEK J., PIASECKI E. and SYPUŁA A. (1994): Interferon responses in schizophrenia and major depressive disorders. Biol. Psychiatry, 35, 464-473.
11. INGLOT A D., PIASECKI E., ZACZYŃSKA E. and ZIELIŃSKA-JENCZYLIK J. (1992): Seleno-organic compounds induce interferon and tumor necrosis factor in human but not in rat or mouse lymphoid cells. Arch Immunol Ther Exp., 40, 169-173.
12. INGLOT A. D, ZIELIŃSKA-JENCZYLIK J. and PIASECKI E. (1993): Tolpa* Torf Preparation (TTP*) induces interferon and tumor necrosis factor production in human peripheral blood leukocytes Arch. Immunol. Ther Exp., 41, 73-80.
13. INGLOT A. D., ZIELIŃSKA-JENCZYLIK J., PIASECKI E., SYPER L. and MŁOCHOWSKI J. (1990): Organoselenides as potential immunostimulants and inducers of interferon gamma and other cytokines in human peripheral blood leukocytes. Experientia, 46, 308-311.
14. KIREMIDJIAN-SCHUMACHER L, ROY M., WISHE H. I., COHEN M. W. and STOTZKY G. (1992): Regulation of cellular immune responses by selenium. Biol. Trace Elem. Res., 33, 23-35.
15. MŁOCHOWSKI J., KLOC K., SYPER L., INGLOT A. D. and PIASECKI E. (1993): Aromatic and azaaromatic diselenides, benzisoselenazolones and related compounds as immunomodulators active in humans: synthesis and properties. Liebigs Ann. Chem., 1239-1244.
16. PARNHAM M. J., DOWLING E. J., BROQUET C. and BRAQUET P. (1994): Seleno-organic compounds as potential pharmaceuticals Proceedings of the Fifth International Symposium on the Uses of Selenium and Tellurium. Brussels 8 -10.05.1994, p. 75-80.
17. PARNHAM M. J. and GRAF E. (1987): Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Biochem. Pharmacol., 36, 3095-3102.
18. PARNHAM M. J., LEYCK S, GRAF E., DOWLING E. J. and BLAKE D. R. (1991): The pharmacology of ebselen. Agents Actions, 32, 4-9.
19. PIASECKI E., INGLOT A. D., ZIELIŃSKA-JENCZYLIK J., MŁOCHOWSKI J. and SYPER L. (1992): Simultaneous induction of Interferon gamma and tumor necrosis factor alpha by different seleno-organic compounds in human peripheral blood leukocytes. Arch Immunol., Ther. Exp., 40, 229-234.
20. + patients as markers for monitoring of the AIDS progression. Arch. Immunol. Ther. Exp., 42, 439-445.
21. R in treatment of mouth and ear herpetic infections: comparison with conventional therapy. Arch. Immunol. Ther. Exp., 41, 137-140.
22. SCHRAUZER G. N. and SACHER J. (1994): Selenium in the maintenance and therapy of HIV-infected patients. Chem. Biol. Interact., 91, 199-205.
23. SIES H. (1993): Ebselen, a seleno-organic compound as glutathione peroxidase mimic. Free Radic. Biol. Med., 14, 313-323.
24. TAYLOR E. W., RAMANATHAN C. S., JALLURI R. K. and NADIMPALLI R. G. (1994): A basis for new approaches to the chemotherapy of AIDS: novel genes in HIV-1 potentially encode selenoproteins expressed by ribosomal frameshifting and termination suppression. J. Med. Chem., 37, 2637-2654.
25. WAGNER G., SCHUCH G., AKERBOOM T. P. M. and SIES H. (1994): Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte. Biochem. Pharmacol., 48, 1137-1144.